Somatoform Disorder in British South Asians
NCT02349256 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2015-01-28
Summary
The study uses in depth interviews to understand their experience of somatoform disorder, possible explanations and their experience of somatoform disorder, possible explanations and their understanding of treatments, especially their ideas about psychosocial treatments.
Conditions
- Somatic Syndrome Disorder
Sponsors & Collaborators
-
University of Manchester
collaborator OTHER -
Global Health Primary Care Research and Innovation and Network
lead OTHER
Principal Investigators
-
Saif Bhojani · Research Manager
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2015-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Metacognitive Therapy for Social Anxiety in Youth
NCT03514225 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Treatment for Generalized Anxiety Disorder
NCT00456742 ·Status: COMPLETED
-
Pain Processing in Anxiety and Depression
NCT00560196 ·Status: COMPLETED
-
Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)
NCT04220996 ·Status: COMPLETED ·Phase: PHASE4
-
Brief Shame Intervention Study
NCT03463356 ·Status: COMPLETED ·Phase: NA
-
Reappraisal Of Medical Assurance (ROMA): An Experimental Study in Patients With Functional Somatic Symptoms
NCT04044469 ·Status: COMPLETED ·Phase: NA
-
A Dose-Response Safety Study of ENX-102 in Patients With GAD
NCT06653296 ·Status: COMPLETED ·Phase: PHASE2
-
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning
NCT00062517 ·Status: COMPLETED
-
Treating Emotional Disorders in Primary Care With Psychological Techniques
NCT01903096 ·Status: COMPLETED ·Phase: PHASE4
-
Social Anxiety Disorder Study Of Paroxetine
NCT00318669 ·Status: COMPLETED ·Phase: PHASE3
-
Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder
NCT06693609 ·Status: COMPLETED ·Phase: PHASE2
-
Project EMPOWER-OCD
NCT07158801 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Impact of COVID-19 on Mental Health of OCD Patients and live-in Family Members
NCT05656456 ·Status: COMPLETED
-
Duloxetine for the Treatment of Generalized Anxiety Disorder
NCT00803361 ·Status: COMPLETED ·Phase: PHASE3
-
Oxytocin Administration in BDD and OCD
NCT02671266 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)
NCT04951076 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Treatment for Panic Disorder
NCT00456768 ·Status: COMPLETED
-
Fluoxetine in Pediatric Body Dysmorphic Disorder
NCT00245635 ·Status: COMPLETED ·Phase: PHASE4
-
Arousal Training for Social Anxiety Disorder
NCT02493010 ·Status: COMPLETED ·Phase: NA
-
Gaze Contingent Feedback in Social Anxiety Disorder
NCT02590770 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy Subjects
NCT00538889 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
NCT00470483 ·Status: COMPLETED ·Phase: PHASE1
-
Brief Group Psychotherapy for Anxiety and Depression
NCT04489641 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety
NCT00930293 ·Status: COMPLETED ·Phase: NA
-
Exploring The Metacognitive Beliefs in OCD: A Randomized Controlled Trial of Metacognitive Therapy
NCT07052812 ·Status: COMPLETED ·Phase: NA